OTC drug maker cited for failure to investigate deviations, provide GMP training.(HUMAN DRUGS): An article from: Inspection Monitor

This digital document is an article from Inspection Monitor, published by Washington Information Source, Inc. on May 1, 2010. The length of the article is 805 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: OTC drug maker cited for failure to investigate deviations, provide GMP training.(HUMAN DRUGS)
Author: Unavailable
Publication:Inspection Monitor (Newsletter)
Date: May 1, 2010
Publisher: Washington Information Source, Inc.
Volume: 15 Issue: 5 Page: 2

Distributed by Gale, a part of Cengage Learning